Equillium, Inc.
General ticker "EQ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $168.0M (TTM average)
Equillium, Inc. follows the US Stock Market performance with the rate: 34.5%.
Estimated limits based on current volatility of 4.9%: low 1.25$, high 1.38$
Factors to consider:
- Total employees count: 14 (-60.0%) as of 2025
- Top business risk factors: Failure to achieve profitability, Regulatory and compliance, Manufacturing scale up, Inability to raise capital, Labor/talent shortage/retention
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.42$, 1.41$]
- 2025-12-31 to 2026-12-31 estimated range: [0.48$, 1.52$]
Financial Metrics affecting the EQ estimates:
- Positive: with PPE of -2.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Investing cash flow per share per price, % of 58.62 > 2.08
- Negative: Industry earnings per price (median), % of -21.03 <= 0
- Positive: 69.38 < Shareholder equity ratio, % of 74.45 <= 81.92
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term EQ quotes
Long-term EQ plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.76MM | $36.08MM | $41.09MM |
| Operating Expenses | $77.83MM | $50.61MM | $49.36MM |
| Operating Income | $-62.08MM | $-14.52MM | $-8.27MM |
| Non-Operating Income | $-0.35MM | $1.77MM | $0.56MM |
| Interest Expense | $1.05MM | $0.49MM | $0.00MM |
| R&D Expense | $60.60MM | $37.04MM | $37.43MM |
| Income(Loss) | $-62.43MM | $-12.76MM | $-7.71MM |
| Taxes | $0.00MM | $0.58MM | $0.36MM |
| Net Income(Loss)* | $-62.43MM | $-13.34MM | $-8.07MM |
| Stockholders Equity | $31.94MM | $22.57MM | $19.06MM |
| Assets | $78.42MM | $50.53MM | $25.60MM |
| Operating Cash Flow | $-8.73MM | $-21.78MM | $-19.03MM |
| Capital expenditure | $0.28MM | $0.05MM | $0.09MM |
| Investing Cash Flow | $18.68MM | $-4.76MM | $13.81MM |
| Financing Cash Flow | $-1.22MM | $-9.23MM | $0.16MM |
| Earnings Per Share** | $-1.85 | $-0.38 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.